Back to Search Start Over

A bibliometric analysis of research on (R)-ketamine from 2002 to 2021.

Authors :
He, Teng
Wang, Di
Wu, Zifeng
Huang, Chaoli
Xu, Xiangyang
Xu, Xiangqing
Liu, Cunming
Hashimoto, Kenji
Yang, Chun
Source :
Neuropharmacology. Nov2022, Vol. 218, pN.PAG-N.PAG. 1p.
Publication Year :
2022

Abstract

Anesthetic ketamine is a racemic mixture containing equal amount of (R)-ketamine and (S)-ketamine. Increasing preclinical data show that (R)-ketamine has a rapid-onset and sustained antidepressant without significant side effects. There are currently many studies on (R)-ketamine, however, the quantity and quality of these studies are unknown. Therefore, we conducted a bibliometric analysis of research on (R)-ketamine from January 2002 to December 2021. We obtained the publications on (R)-ketamine from the Web of Science database during the period. A variety of bibliographic elements were collected, including annual publications, authors, countries/regions, institutions, journals, and keywords. A total of 922 publications were included in this study. Professor Kenji Hashimoto of Chiba University in Japan was the most productively influential author in the field of (R)-ketamine and the authors from United States were the leader in this field. In addition, we found that the antidepressant effect of (R)-ketamine has been a hotspot in very recent years. This study provided a comprehensive analysis of research on (R)-ketamine and highlighted the growing interest in (R)-ketamine and its antidepressant effects. • A total of 922 publications on (R)-ketamine from January 2002 to December 2021 were analyzed. • Professor Kenji Hashimoto of Chiba University was the most productively influential author in the field of (R)-ketamine. • The antidepressant effect of (R)-ketamine has been a hotspot in recent years. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00283908
Volume :
218
Database :
Academic Search Index
Journal :
Neuropharmacology
Publication Type :
Academic Journal
Accession number :
158910011
Full Text :
https://doi.org/10.1016/j.neuropharm.2022.109207